Dr. Khurana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2016
- University of ConnecticutResidency, Internal Medicine, 2012 - 2015
- Maulana Azad Medical CollegeClass of 2010
Certifications & Licensure
- MN State Medical License 2019 - 2025
- VA State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 33 citationsDoes bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley Stish
Radiotherapy and Oncology. 2022-01-01 - 59 citationsMDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388).Arushi Khurana, Danielle Shafer
Oncotargets and Therapy. 2019-04-16 - 5 citationsPatterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.Arushi Khurana, Raphael Mwangi, Stephen M. Ansell, Thomas M. Habermann, James R. Cerhan
Blood Cancer Journal. 2021-07-17
Press Mentions
- Eligibility Criteria More Likely to Exclude Minorities from Lymphoma Clinical TrialsDecember 10th, 2022
- 6 Mayo Clinic Staff Selected for Diversity in Clinical Trials Career Development AwardOctober 26th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: